Incidence of Major Bleeding in Patients with Pulmonary Thromboembolism Treated with Fixed Dose Alteplase 100 mg

BACKGROUND: Acute pulmonary thromboembolism (PTE) is a critical cardiopulmonary condition associated with high mortality and morbidity. In massive PTE, recently referred to as high risk PTE, the routine protocol for thrombolysis with recombinant tissue plasminogen activator (alteplase) is 100 mg ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Dae-Hwan, Lee, Won Jae, Shin, Yoon Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445310/
https://www.ncbi.nlm.nih.gov/pubmed/32830464
http://dx.doi.org/10.3346/jkms.2020.35.e267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445310/
https://www.ncbi.nlm.nih.gov/pubmed/32830464
http://dx.doi.org/10.3346/jkms.2020.35.e267

Ejemplares similares